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In continuation of our interest towards the elucidation of apoptotic pathways of cytotoxic phytocompounds, we have embarked
upon a study on the anticancer eﬀects of 7α-hydroxy-β-sitosterol (CT1), a rare natural phytosterol oxide isolated from Chisocheton
tomentosus. CT1 was found to be cytotoxic on three diﬀerent human tumor cell lines with minimal eﬀects on normal cell controls,
where cell viability levels were maintained ≥80% upon treatment. Our results showed that cell death in MCF-7 breast tumor
cells was achieved through the induction of apoptosis via downregulation of the ERK1/2 signaling pathway. CT1 was also found
to increase proapoptotic Bax protein levels, while decreasing anti-apoptotic Bcl-2 protein levels, suggesting the involvement
of the intrinsic pathway. Reduced levels of initiator procaspase-9 and executioner procaspase-3 were also observed following
CT1 exposure, confirming the involvement of cytochrome c-mediated apoptosis via the mitochondrial pathway. These results
demonstrated the cytotoxic and apoptotic ability of 7α-hydroxy-β-sitosterol and suggest its potential anti-cancer use particularly
on breast adenocarcinoma cells.
1. Introduction
The tropical plant Chisocheton tomentosus from the Meli-
aceae family is a medium-sized tree that can grow upto 21m
in height [1]. Chisocheton species were known to produce
bioactive compounds with complex molecular structures
such as erythrocarpine E and chisomecine A [2, 3]. Plants
from this family have been known to be a rich source of sec-
ondarymetabolites including various sterols, terpenoids, and
alkaloids, with medicinal and pesticidal properties such as
antifungal, antibacterial, antiviral, anti-inflammatory, and
antiplasmodial agents [4–6]. In tropical countries, this plant
has been used as a form of traditional medicine against
several diseases including diabetes, malaria, liver, and cancer
diseases [7–9].
Plant-derived sterols or phytosterols are structurally
similar to cholesterol with a slight diﬀerence at the C-24
position containing an additional ethyl group [10]. About 44
phytosterols have been identified to date, with major forms
existing in higher plants constituted by β-sitosterol, campes-
terol, and stigmasterol [11–14]. Past studies have also shown
that β-sitosterol possesses a relatively large dipole moment,
giving it a polar or hydrophilic nature which is a desirable
trait in most in vivo drug applications [13]. β-sitosterols have
also been reported to bind various carrier proteins such as
human serum albuminmainly by hydrophobic and hydrogen
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bond interactions, thus making protein-drug combination
complexes a viable option for chemotherapy [15].
Sitosterols often undergo oxidation processes to form
sitosterol oxidation products (SOPs) [16]. These forms
of sterols are structurally diﬀerent from parent with an
additional steroid ring group of either hydroxy- (OH–), keto
(=O), epoxy, or triol [17]. Various forms of SOP that
exist in human plasma are β-epoxysitostanol, sitostanetriol,
campestanetriol, α-epoxysitostanol, 7-ketositosterol, and
7β-hydroxysitosterol, with β-epoxysitostanol, sitostanetriol,
and campestanetriol being the most abundant SOPs
[18].
In recent years, researchers have been focusing on the
eﬀects of phytosterols toward various cancer cell lines
and their implication in multidrug resistance [19–21]. To
date, several apoptotic pathways mediated by phytosterols
have been proposed in cancer culture models such as the
Ras/ERK and the PI3 K/Akt pathway [22–26]. In contrast,
investigation on the mechanistic eﬀects of phytosterol oxides
is still scarce. Despite several reports on the cytotoxicity of
these compounds, their cytotoxic mechanism of action is,
however, still unclear [18, 27]. Roussi et al. [28] suggested
that 7β-hydroxysitosterol, one of the many phytosterol
oxides, could target the mitochondria, leading to loss of
mitochondrial membrane potential to induce cytochrome c
release. However, themechanism of cytochrome c release and
caspase activation was not well characterized [28–30].
In this study, the cytotoxic eﬀects of 7α-hydroxy-β-
sitosterol (CT1) isolated from Chisocheton tomentosus (Meli-
aceae) was investigated on human breast, liver, and oral
cancer cell lines, while its apoptotic potential and anticancer
mechanism was elucidated on MCF-7 human breast cancer
cell line for the first time.
2. Materials and Methods
2.1. Plant Material. Dried bark of Chisocheton tomentosus
was collected from Mersing, Johor, Malaysia in 1993. The
sample was identified by Mr. Teo from the Department of
Chemistry, Faculty of Science, University of Malaya. A
voucher specimen KL-4251 was deposited in the Department
of Chemistry Herbarium, University of Malaya.
2.2. Reagents. Dulbecco’s modified Eagle’s medium
(DMEM) and Roswell ParkMemorial Institute-1640 (RPMI-
1640) were purchased from Thermo Scientific (IL, USA).
Trypsin and fetal bovine serum (FBS) were purchased from
Sigma Aldrich (KS, USA). Mammary epithelial growth
media (MEGM) and all antibiotics were purchased from
Lonza Inc. (MD, USA). Dimethyl-2-thiazolyl-2,5-diphenyl-
2H-tetrazolium bromide (MTT) reagent, annexin V-flu-
orescein isothiocyanate (FITC) apoptosis detection kit,
propidium iodide (PI), RNase and SuicideTrack DNA
ladder isolation kit were purchased from Calbiochem (CA,
USA). Primary antibodies against caspase-9, caspase 3,
caspase-6, caspase-8, XIAP, Bcl-2, Bax, Bim, Fas-L, p42/44,
and β-actin were obtained from Cell Signaling (MA,
USA).
2.3. Extraction and Isolation Compounds. Dried ground bark
of Chisocheton tomentosus (3.5 kg) was first defatted with
hexane for five days, followed by dichloromethane (DCM)
for five days. DCM was removed through evaporation using
a rotary evaporator. The crude extract (10.0 g) was subjected
to a silica gel column (hexane : DCM, 95 : 5) and eluted
gradiently using hexane : DCM and DCM : acetone to yield
five fractions. The fifth fraction (DCM : acetone, 60 : 40) was
further subjected to an isocratic separation using a silica gel
columnwith (acetone : DCM : hexane, 25 : 25 : 50) to give five
other fractions. The third fraction in the solvent was allowed
to evaporate to yield colorless crystals of 7α-hydroxy-β-
sitosterol or CT1 (0.2 g). Identification of CT1 was elucidated
by comparison with known samples by their UV, IR, 1D-
NMR, and 2D-NMR spectra and melting points [31]. A
complete description of the entire extraction process and
identified compounds is available under Supplementary
Material 1 (see Supplementary Material available online at
doi: 10.1155/2012/765316).
2.4. Cell Lines and Culture Conditions. A set of four human
tumor cell lines were used in this study: Ca Ski cervical
cancer cells and HepG2 liver cancer cells which was obtained
from Professor Dr. Rohana, University of Malaya Medical
Center (UMMC), HSC-4 oral cancer cells and MCF-7
breast adenocarcinoma cells were obtained from Dr. Eswary
Thirthagiri, Cancer Research Initiative Foundation (CARIF,
Malaysia), and HMEC human mammary epithelial cells
purchased from Lonza Inc. (MD, USA) was used as a
normal cell control. For routine maintenance, MCF-7 cells
were cultured in RPMI-1640, while HSC-4, Ca Ski, and
HepG2 cells were cultured in DMEM, with both media types
supplemented with 10% (v/v) FBS, 100U/mL penicillin,
and 100mg/mL streptomycin. HMEC cells were cultured
in serum-free mammary epithelial growth media (MEGM).
Cells were grown as monolayers at 37◦C in humidified
atmosphere with 5% CO2 and 95% air.
2.5. MTT Cell Viability Assay. Cell viability was measured
using the MTT assay method. Briefly, CT1 was dissolved
in dimethyl sulfoxide (DMSO) to a final concentration of
10.0mM. Cells were seeded at 1.0 × 104 cells/well in 96-
well plates and treated with final CT1 concentrations from
0.5 to 80.0 μM for 24 h with DMSO as a solvent control.
After treatment, 10.0 μL MTT (5.0mg/mL) was added to
each well and incubated at 37◦C for 2 h. After incubation,
the medium was replaced with 200.0 μL of DMSO and
absorbance measured at 570 nm for each well using a
microplate reader (Tecan Sunrise, Switzerland). Absorbance
was compared against vehicle-treated control and expressed
as mean percentage of viable cells.
2.6. Live/Dead Assay. Cytotoxic eﬀects of four cell lines
treated with CT1 were performed using LIVE/DEAD via-
bility/cytotoxicity kit for mammalian cells (Invitrogen, NY,
USA) according to manufacturer’s protocol. Briefly, cells
were grown on cover slips and treated for 12 h. Staining
was done using a 150.0 μL dual fluorescence staining system
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Figure 1: (a) Molecular structure of 7α-hydroxy-β-sitosterol (CT1). The ellipsoids denote 70% probability. Hydrogen atoms are drawn as
spheres of arbitrary radii [33]. (b) Chemical structure of 7α-hydroxy-β-sitosterol isolated from Chisocheton tomentosus bark.
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Figure 2: Live/dead viability/cytotoxicity assay depicting the cytotoxic eﬀects of CT1 in tumor cell lines with minimal cytotoxic eﬀects on
HMEC normal cell controls. (a) Fluorescence microscope images of viable cells stained with acetomethoxy derivate of calcein (green) and
nonviable cells stained with ethidium homodimer 1 (red). (b) Percentage of viable cells as calculated under a fluorescence microscope. A
total of four random quadrants were selected from each triplicate for quantification. All data were presented as mean ± SEM.
4 Evidence-Based Complementary and Alternative Medicine
Table 1: 1D (1H and 13C) and 2D (HMQC and HMBC) NMR spectral data of of 7α-hydroxy-β-sitosterol (CT1).
Position δH (int.; mult.; J (Hz)) δc HMQC HMBC
1a 1.80 (1H, m) 37.08 Ha–C1 1, 3, 5, 10
1b 1.01 (1H, m) Hb–C1 1, 3, 5, 10
2a 1.80 (1H, m) 31.3 Ha–C2 1, 3
2b 1.47 (1H, m) Hb–C2 1, 3
3 3.54 (1H, m) 71.3 H–C3
4 2.29 (2H, d, 5) 42.0 H2–C4 2, 5, 6, 10
5 146.3
6 5.55 (1H, d, 5.0) 123.8 H–C6 4, 7, 8, 10
7 3.81 (1H, brs) 65.4 H–C7 5, 6, 9
8 1.43 (1H, m) 37.5 H–C8 14, 10, 4, 13, 9
9 1.15 (1H, m) 42.3 H–C9 8, 10, 11, 12, 19
10 37.4
11 1.49 (2H, m) 20.7 H2–C11 9, 10, 12, 13
12a 1.97 (1H, m) 39.2 Ha–C12 9, 13, 14
12b 1.12 (1H, m) Hb–C12 9, 13, 14
13 42.2
14 1.41 (1H, m) 49.4 H–C14 15, 16, 17, 18
15a 1.66 (1H, m) 24.3 Ha–C15
15b 1.08 (1H, m) Ha–C15
16a 1.83 (1H, m) 28.3 Ha–C16 13, 20, 21
16b 1.22 (1H, m) Ha–C16 13, 20, 21
17 1.14 (1H, m) 55.7 H–C17 18, 21, 15, 16
18 0.65 (3H, s) 11.7 H3–C18 12, 13, 14, 17
19 0.95 (3H, s) 19.2 H3–C19 1, 2, 9, 10, 11
20 1.33 (1H, m) 36.1 H–C20 17, 18, 23, 24
21 0.89 (3H, d, 6.4) 18.3 H3–C21 17, 20, 22
22 2.24 (2H, m) 33.8 H2–C22
23 1.22 (2H, m) 29.8 H2–C23 22, 24, 25
24 0.93 (1H, m) 49.4 H–C24 29, 26, 27
25 1.64 (1H, m) 29.0 H–C25 24, 26, 27, 28
26 0.81 (3H, m) 19.9 H3–C26 24, 28
27 0.77 (3H, m) 18.9 H3–C27 24, 25, 26
28 1.22 (2H, m) 23.1 H2–C28 23, 24, 25, 27, 29
29 0.83 (3H, m) 12.1 H3–C29 23, 24, 25, 28
consisting of calcein acetoxymethyl ester (2.0 μM) and
ethidium homodimer (4.0 μM). Excitation and emission
wavelengths of both fluoresceins were set at 494/517 nm for
calcein acetoxymethyl ester and 528/617 nm for ethidium
homodimer, respectively. Samples images were capture using
a Nikon Eclipse TS-100 fluorescence microscope (Nikon,
Tokyo, Japan) under 100x magnification. All images were
analyzed using the NIS Element D 3.1 data analysis software
(Nikon, Tokyo, Japan).
2.7. Wound Healing Assay. Wound healing was used to
examine the antimigration eﬀects of CT1 on cancer cells.
Briefly, cells were grown on 6-well plates for 24 h followed by
treatment with mitomycin-c for 2 h. Media was removed and
equal size wounds were created with a pipette tip. Cells were
washed twice with 1x PBS and serum free media was added.
Each group was incubated with media only, DMSO, or CT1
for 24 h. Images were captured using a Nikon Eclipse TS-100
fluorescence microscope (Nikon, Tokyo, Japan) under 100x
magnification and analyzed using T-Scratch software v7.8
[32].
2.8. Cell Cycle Analysis. Both MCF-7 and HMEC cells were
treated with CT1 for 12 h and 24 h before fixation. Briefly,
1.0 × 105cells was pelleted, rinsed with 1x PBS, and fixed
with 70% (v/v) cold ethanol while mixing. Fixed samples
were stored at −20◦C overnight and stained with 1.0mL
of PBS containing 50.0 μg/mL PI and 0.1mg/mL RNase A.
Fluorescence from a population of 1.0 × 104 cells were
detected using the FASCanto II (Becton Dickinson, CA,
USA) and analyzed using the ModFit Lt 3.2 software (Tree
Star Inc, OR, USA).
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Table 2: Summary of IC50 values and total cell viability of CT1-treated tumor cell lines and HMEC cells as obtained from MTT cell viability
assays after 24 h exposure. All data are presented as mean± SEM after deduction of DMSO solvent-induced cytotoxicity of three independent
experiments.
Cell lines Time (H) IC50 (μM)† Cell viability (%)
Human mammary epithelial cell (HMEC)
24 n.d 82.4± 4.2
48 n.d 80.3± 5.6
Human breast adenocarcinoma (MCF-7)
6 n.d 45.5± 5.5
12 38.2± 3.2 36.5± 1.9
18 28.6± 4.1 29.3± 1.4
24 16.0± 3.6 21.3± 3.1
Human hepatocyte carcinoma (HepG2)
6 76.8± 5.2 35.9± 8.4
12 74.0± 4.3 32.5± 9.3
18 75.0± 5.1 26.8± 7.2
24 25.0± 3.3 25.2± 3.6
Human oral squamous cell carcinoma (HSC-4)
6 30.3± 2.4 48.6± 1.7
12 28.8± 5.1 48.1± 1.0
18 24.2± 3.1 43.2± 4.3
24 19.5± 2.6 40.6± 3.2
Human cervical carcinoma (Ca Ski)
6 n.d 94.6± 4.2
12 82.9± 4.7 73.7± 7.7
18 88.3± 6.3 58.8± 4.8
24 96.5± 5.3 60.7± 3.6
†
n.d denotes that total cell viability was maintained >50% viability at maximum incubation time and CT1 concentration.
2.9. Annexin V-FITC/PI Analyses. Detection of apoptosis was
conducted using the Annexin V-FITC/PI apoptosis detection
kit according to manufacturer’s protocol. Briefly, both CT1-
treated and untreated MCF-7 and HMEC cells were washed
twice with 1x PBS and resuspended in binding buﬀer. Cell
suspensions were stained with 1.25 μL of annexin V-FITC
conjugate and 10.0 μL of PI. Detection of signals from 1.0
× 104 cells were obtained using the FASCanto II (Becton
Dickinson, CA, USA) and analyzed using the FACS Diva
acquisition and analysis software (Becton Dickinson, CA,
USA).
2.10. DNA Fragmentation Assay. Detection of apoptotic
fragmented DNA was performed using the Suicide-Track
DNA isolation kit according to manufacturer’s protocol.
After 24 h of incubation with CT1 cells were collected and
total DNAwas extracted from cells. Samples were loaded into
a 1.5% (w/v) agarose gel and separated by electrophoresis.
DNA fragments were stained with ethidium bromide and
were visualized under UV illumination using the Alpha
Imager Gel Documentation System 2000 (Inotech, CA,
USA).
2.11. Western Blot. To determine pro- and antiapoptotic pro-
tein levels, CT1-treated MCF-7 total proteins were extracted
using the NE-PER nuclear and cytoplasmic extraction kit
(Pierce, IL, USA) according to manufacturer’s protocol.
Protein concentrations were determined using the Bio-Rad
DC protein assay (Bio Rad, CA, USA) according to manu-
facturer’s protocol. Equal amounts of protein were subjected
to 12% to 15% (w/v) SDS-PAGE and transferred onto
0.2 μMnitrocellulose membranes using a Trans Blot Semidry
blotter (Bio Rad, CA, USA). Membranes were blocked either
with 2% (w/v) BSA or 2% (w/v) nonfat skim dry milk,
and incubated with primary antibodies against β-actin,
Bax, Bcl-2, Bim, caspase-6, caspase-3, caspase-9, caspase-8,
XIAP, FasL, and ERK1/2. Horseradish peroxidase-(HRP-)
linked secondary antibodies were added and bound proteins
were detected through enhanced chemiluminescence reagent
exposed on X-ray films. Relative intensities of bands were
quantified using the ImageJ v1.43 analysis software (NIH,
MD, USA).
2.12. Statistical Analysis. All results were expressed as
mean ± SEM obtained from three independent experi-
ments. Statistical significances between various groups were
determined using one-way ANOVA with a P value ≤0.05
threshold.
3. Results and Discussion
3.1. Characterization of 7α-Hydroxy-β-Sitosterol (CT1). CT1
was isolated as a colorless crystal with the UV spectrum
showing absorption at λmax 302 nm and 254 nm, IR spectrum
showing the presence of hydroxyl group by the absorption
band at νmax 3430 cm−1, and GCMS spectrum revealing a
molecular ion peak [M]+ at m/z 430, corresponding to a
molecular formula of C29H50O2. The 1H-NMR spectrum
showed six methyl groups resonating as singlets, doublets,
and triplets. Broadband decoupled 13C-NMR spectrum dis-
played twenty-nine carbon atoms in the molecule, the DEPT
spectra exhibited six methyl, ten methylene, and ten methine
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Figure 3: CT1 potentiates apoptosis-mediated cell death in MCF-7 human breast cancer cells. (a) Detection of apoptosis using flow
cytometry after annexin V-FITC/propidium iodide (PI) staining. MCF-7 cells and HMEC cells were treated with CT1 at IC50 concentrations
for 24 h. Dot plots are a representative of 1.0 × 104 cells of three replicates with percentage of cells indicated in each quadrant. (b)
Confirmation of apoptosis-mediated cell death through observation of a 200 to 250 bp DNA laddering using the DNA fragmentation assay.
Cells were treated with CT1 for 24 h followed by analysis of extracted DNA on 1.0% (w/v) agarose gel electrophoresis. +ve: positive control.
M: 100 bp DNA size marker.
carbons, while the remaining three carbons were quaternary
as deduced from broadband spectrum. All protons of methyl,
methylene, sp3 methine, and sp2 methine were approved by
HMQC. HMBC spectrum showed long range correlation of
C-19 proton with quaternary carbon of C-10, while C-18
methyl protons showed HMBC connectivity with quaternary
C-13, indicating that the methyl group (19 and 18) was
attached directly with C-10 and C-13, respectively, and the
long chain substituent should be attached in the position of
C-17 (Table 1). The signal C-5 (δc 146.3) of the compound
was shifted toward the lower magnetic field (Figure 1(a))
[33]. Therefore, the configuration of hydroxyl group at C-7
was identified as an α form [34–37]. Consequently, CT1 was
identified as 7α-hydroxy-β-sitosterol. (Figure 1(b)).
3.2. CT1 Displayed Cytotoxic Eﬀects on Various Cancer Cell
Lines. MTT cell viability assay was used to evaluate the
cytotoxic eﬀects of CT1 on four human cancer and anHMEC
normal cell line. Results indicated the induction of cytotox-
icity in a dose- and time-dependent manner over 24 h of
exposure. Minimal cytotoxic eﬀects were observed onHMEC
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Figure 4: Cell cycle distribution ofMCF-7 andHMEC cells using flow cytometry after staining with PI for 12 h and 24 h. I: Sub-G1; II: G0/G1;
III: S; IV: G2/M. All experiments were a representative of 1.0 × 104 cells and the percentage of cells in phases is indicated.
control cells, where 17.6 ± 4.2% killing was observed under
similar treatment conditions, as opposed to 78.7 ± 3.1% in
MCF-7 cells which indicated the lowest IC50 value of 16.0 ±
3.6μM among all cell lines tested (Table 2). Viability of cells
treated with DMSO (≤2.0% v/v) was insignificantly aﬀected
(data not shown), thereby ruling out the occurrence of
solvent-induced cytotoxicity. Live/dead viability/cytotoxicity
assays (Figures 2(a) and 2(b)) corresponded with MTT
data, thereby supporting the need to further investigate the
apoptotic eﬀects of CT1 for the treatment of breast cancer.
All subsequent experiments were carried out based on IC50
values as obtained from MTT experiments.
3.3. CT1 Induces Apoptosis-Mediated Cell Death. We next
determined whether CT1 cytotoxic eﬀects were mediated
through apoptosis or necrosis using DNA fragmentation
assay and double fluorescence staining of annexin V-FITC/PI
flow cytometry assay. An increase in cellular staining with
FITC-conjugated annexin-V serves as an early marker for
apoptosis while staining with PI indicates loss of cell
membrane integrity. Treatment of MCF-7 cells was found
to induce apoptotic cell death by observing a shift in viable
cell population from early to late stage of apoptosis, followed
by secondary necrosis. The percentage of MCF-7 viable
cells decreased from 91.2% to 45.1%, while total per-
centage of apoptotic MCF-7 cells was 46.6% after 24 h
(Figure 3(a)). Minimal apoptotic population shifts were
observed in HMEC cells after similar treatments. DNA
extracted from CT1-treated cells also showed DNA laddering
with approximately 200 bp to 250 bp intervals as the result
of endonuclease action at sites between nucleosomes, thus
confirming the occurrence of apoptosis (Figure 3(b)).
3.4. Induction of Cell Cycle Arrest and Antimigration Eﬀects
of CT1. The eﬀects of CT1 on cell cycle progression using
flow cytometry PI-based staining showed an increase in
the population of sub-G1 phase from 11.1% to 55.0%
after 24 h incubation. The increase was consistent with a
reduction in the G0/G1 phase from 70.8% to 35.0% after
24 h indicating a potential cell cycle arrest during the G0/G1
phase as there were minimal changes in both S and G2/M
phases after 24 h of CT1 treatment (Figure 4). Cell cycle
profiles for HMEC normal human breast cell controls were
found to be consistent after 12 h and 24 h exposure. Wound
healing assays also showed that HSC-4 cells treated with
CT1 migrated at a slower rate compared to MCF-7 cells,
indicating that CT1 was more eﬀective in preventing cellular
migration in oral cancer (Figure 5). Antimigration eﬀects
on HepG2 cells were found to be absent with treated cells
showing comparable migration rates as untreated cells (data
not shown).
3.5. CT1 Reduces ERK1/2, FasL, Bcl-2, and Bim Protein
Levels. Western blot analysis of CT1-treatedMCF-7 cells was
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Figure 5: Wound healing assay displaying the antimigration eﬀects of CT1 on HSC-4 cells, with minimal eﬀects on MCF-7 cells. All cells
were treated withmitomycin c to halt proliferation, followed by CT1 at IC50 concentrations for 12 h.Wound edge images of each independent
triplicate were captured and measured at 24 h aftertreatment using T-scratch software, and percentage of migration is indicated as mean ±
SEM.
carried out to observe the eﬀects on ERK1/2, FasL, and Bcl-
2 family of apoptotic proteins. Results showed that protein
levels of both ERK1 and ERK2 declined over 24 h, while
the level of the FasL increased dramatically by almost five-
folds over 24 h compared to untreated cells (Figures 6(a) and
6(b)). Protein levels of the pro-apoptotic Bim and Bcl-2 also
decreased after CT1 treatment and were completely absent
12 h aftertreatment, favoring the induction of apoptosis
(Figures 6(a) and 6(b)). Furthermore, protein levels of pro-
apoptotic Bax were found to be slightly elevated after 24 h,
with consistent XIAP protein levels. Due to the dimerization
nature of Bcl-2 family proteins, the ratio between Bax/Bcl-
2 protein levels were measured and indicated a 9.7-fold
increase at 12 h, which further increased to 26.6-folds higher
compared to control cells at 24 h (Figures 6(a) and 6(b)).
3.6. CT1 Induces Intrinsic Caspase-Mediated Apoptosis in
MCF-7 Cells. The involvement of FasL and Bcl-2 family
members implied that induction of apoptosis by CT1 was
mediated via both the mitochondrial and death receptor
pathway. Therefore, we also assessed the protein levels of
various procaspases through Western blot analysis. Our
data demonstrated that CT1 induced the reduction of
procaspase-3, -6, and -9 levels leading to an increase in active
eﬀector caspase forms (Figures 7(a) and 7(b)). Reduction
in procaspase-8 protein levels was found to be transient
over the first 6 h with protein levels starting to increase 12 h
aftertreatment onwards, suggesting that the extrinsic death
receptor pathway was used to augment the apoptotic signals
arising from the intrinsic pathway.
4. Discussion
To date, natural plant compounds have shown great potential
as apoptosis-inducing agents in cancer cells [38]. Results
from this study clearly indicated the potential benefits of
phytosterol oxides, specifically 7α-hydroxy-β-sitosterol in the
prevention of breast adenocarcinoma. Current cytotoxicity
data have demonstrated that IC50 values of CT1 after 24 h
of incubation on all cancer cell lines tested were within
the range of 16.0 μM to 32.0 μM, which is comparable to
most commercialized phytocompounds. It is suggested that
variations in CT1 toxicity in diﬀerent cancer types may be
attributed to various reasons including cellular accessibility,
genetic variability of cell lines, and circadian variations [39].
In terms of structure-activity relationship, we found that
the presence of a 7α-OH on CT1 augmented its cytotoxicity
towards HepG2 cancer cells when compared to 7β-OH
sitosterols [40]. Sitosterol derivatives with an oxidized steroid
ring were also found to be a more favorable trait compared
to oxidized stigmasterol derivatives following reports on
cytotoxicity levels in MCF7 and HepG2 cells [10, 41].
These observations highlighted the importance of 7α-OH
phytosterols in governing in vitro biological activity and
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Figure 6: Observation on the eﬀects of CT1 treatment over 24 h on MCF-7 protein levels using Western blot. (a) CT1 was found to decrease
ERK1/2 and anti-apoptotic Bcl-2 and Bim protein levels, while increasing FasL protein levels. XIAP and proapoptotic Bax protein levels
were unaﬀected following CT1 exposure. β-actin was used as a normalization control for all experiments. (b) Quantification of protein band
intensities were determined by densitometry analysis and normalized to β-actin using the ImageJ v1.43 software. All results were presented
as mean normalized intensity ± SEM of three independent experiments.
0 6 12 24 (h)
Procaspase-9
Procaspase-3
Procaspase-6
Procaspase-8
β-actin
(a)
0
0.5
1.5
N
or
m
al
iz
ed
 in
te
n
si
ty
0 h
6 h
12 h
24 h
P
ro
ca
sp
as
e-
9
P
ro
ca
sp
as
e-
3
P
ro
ca
sp
as
e-
6
P
ro
ca
sp
as
e-
8
1
(b)
Figure 7: Activation of caspases upon CT1 treatment in MCF-7 cells. (a) Western blot analysis on protein levels of various procaspases
upon CT1 treatment. MCF-7 cells was treated with 16.0 μM of CT1 for 6 h, 12 h, and 24 h, respectively. Western blot of cell extracts were
probed using the indicated procaspase antibodies and β-actin as a normalization control. (b) Normalization on band intensities between
procaspases and β-actin was determined by densitometry using the ImageJ v1.43 software, and results were presented as a mean normalized
intensity ± SEM of three independent experiments.
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suggested the superiority of CT1 (7α-hydroxy-β-sitosterol)
over other phytosterol counterparts.
One of the crucial factors which contribute towards
proliferating breast cancer cells is the activation of the
mitogen-activated protein kinase (MAPK/ERK) cascade,
which can be prevented by using agents that prevent
ERK1/2 activation [42]. Extracellular signal-regulated kinase
(ERK1/2), which is expressed ubiquitously in mammalian
cells, is multifunctional serine/threonine kinases that phos-
phorylate a vast array of substrates localized in all cellular
compartments [43]. In normal cells, sustained activation of
ERK1/2 promotes G1 to S phase progression and inhibits
antiproliferative genes, while its hypoactivation by MEK
inhibitors can induce cells to undergo cell cycle arrest [44].
Our current study showed that CT1 was able to inhibit
cell cycle progression at the G0/G1 phase after 24 h, which
corresponded to reduced protein levels of ERK1/2 as shown
in our Western blot analysis.
Members of the Bcl-2 family have been identified as key
regulators of apoptosis and are further divided into pro-
apoptotic and anti-apoptotic members [45]. Bcl-2 proteins
often form heterodimer complexes with Bax proteins, which
result in the release of cytochrome c from the mitochondria
and subsequent induction of cell death [46]. Hence, an
increase in the ratio of Bax/Bcl-2 is considered as one of the
major markers of pre-apoptosis. Several natural compounds
that have been shown to influence the Bax/Bcl-2 ratio in
cancer cells are (−)-epigallocatechin-3-gallate (EGCG) and
resveratrol [47, 48]. In reference to this, results of our study
also suggest that CT1 eﬀectively induces apoptosis in MCF-7
cells through dysregulation of the Bax/Bcl-2 ratio, which in
turn results in the cleavage of procaspase-9, -3, and -6 into
active eﬀector caspases.
Western blot analysis also showed that treatment of CT1
not only activates apoptosis eﬀector proteins such as caspase-
3 and caspase-6, which is evident through a decrease in
procaspase-3 and procaspase-6 protein levels, but also acti-
vates caspase-8. This strongly suggests that signals favoring
the induction of apoptosis do not solely originate from the
mitochondrial pathway, but may also be augmented by the
extrinsic death receptor pathway, specifically through Fas-
mediated mechanisms [22]. This is further supported in past
studies revolving caspase cascades indicating that activated
caspase-6 can directly process the transient activation of
caspase-8 through an amplification loop to enhance apop-
totic signals [49]. In agreement with this, we observed an
initial reduction in procaspase-8 levels at 6 h, followed by a
subsequent increase over the next 12 h.
5. Conclusion
For the first time, the biological activity of the active phy-
tocompound, 7α-hydroxy-β-sitosterol (CT1) isolated from
Chisocheton tomentosus, was characterized in various cancer
cell lines. This compound was found to significantly inhibit
the proliferation of MCF-7 human breast cancer cells among
other cancer cell lines through dysregulation of Bax/Bcl-2
ratio and the induction of G0/G1 cell cycle arrest via inacti-
vation of ERK1/2. Despite preliminary evidences describing
the involvement of both caspase-mediated intrinsic and
extrinsic pathways, further elucidation on other apoptotic
targets coupled with in vivo studies are required for further
development of this phytosterol oxide.
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